Proposed Bill Promotes Health Equity Through Focus on Clinical Trial Diversity

In the context of clinical trials, a lack of diverse representation can lead to medicines and vaccines that are less effective in treating disease and health conditions in groups underrepresented in such trials, giving rise to health equity concerns. In the article linked below, Sidley lawyers Stephen Abreu and Mustafa Abdul-Jabbar discusses these issues and concerns.